Home | Welcome to Contract Pharma   
Last Updated Saturday, March 28 2015

Print

Topics - Clinical Trials


Refine by Date:
From: To:
Published March 26, 2015
Expands safety management solutions Read More »
Published March 25, 2015
Will evaluate the safety, tolerability and pharmacokinetics in advanced liver cancer Read More »
Published March 19, 2015
Gains Registered Solution Provider certification Read More »
Published March 19, 2015
Multichannel CRM provides insight and tailored interactions for customer engagement Read More »
Published March 17, 2015
Also initiates pharmacokinetic and pharmacodynamic study Read More »
Published March 17, 2015
Collaboration will evaluate the combination of varlilumab and MPDL3280A Read More »
Published March 13, 2015
First and only clinical trial to reduce hippocampal overactivity during aMCI, the pre-dementia stage of Alzheimer’s disease Read More »
Published March 9, 2015
Vicki Anastasi will lead the new group Read More »
Published March 6, 2015
Advances Phase III Evaluation of SMNRx Read More »
Published March 5, 2015
To provide integrated offering for candidate selection through to early stage trials Read More »
Published March 5, 2015
Will evaluate pembrolizumab, lenvatinib and eribulin in Phase Ib/II trials Read More »
Published March 2, 2015
ALM201 is the company’s first clinical stage program Read More »
Published March 2, 2015
Advances Phase II/III study of ISIS-TTR in FAP Read More »
Published February 25, 2015
Revenues up 13% in the quarter Read More »
Published February 25, 2015
Smith to succeed Ackerman, Hickey takes on Global Discovery Services Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On